Clinical usefulness of autoantibodies in idiopathic inflammatory myositis

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  La Torre, Ignacio García De ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Autoantibodies; Clinical utility of autoantibodies; Inflammatory myositis; Myositis associated antibodies; Myositis specific antibodies

Indexed keywords

AUTOANTIBODY; NUCLEAR RECEPTOR COACTIVATOR 2; SIGNAL RECOGNITION PARTICLE;

ARTICLE; CLINICAL EFFECTIVENESS; DNA REPAIR; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MUSCULAR DYSTROPHY; MYOSITIS; NONHUMAN; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

EID: 84935128572     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00331     Document Type: Article

References (16)

1. Reichlin M, Mattioli M. Description of a serological reaction characteristic of polymyositis. Clin Immunol Immunopathol (1976) 5:12-20. doi:10.1016/0090-1229(76)90145-8.
2. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guideline for the clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med (2000) 124:71-81. doi:10.1043/0003-9985(2000)124<0071;GFCUOT>2.0CO:2.
3. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol (2007) 19:523-9. doi:10.1097/BOR.0b013e3282f01a8c.
4. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum (1980) 23:881-8. doi:10.1002/art.1780230802.
5. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (1991) 70:360-74. doi:10.1097/00005792-199111000-00002.
6. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum (1990) 33:1361-70. doi:10.1002/art.1780330908.
7. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Phychiatry (2002) 73:420-8. doi:10.1136/jnnp.73.4.420.
8. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum (1985) 28:796-803. doi:10.1002/art.1780280711.
9. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi-2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell (1998) 95:279-89. doi:10.1016/S0092-8674(00)81758-4.
10. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyophatic dermatomyositis. Arthritis Rheum (2005) 52:1571-6. doi:10.1002/art.21023.
11. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum (2009) 60:2193-200. doi:10.1002/art.24621.
12. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum (2006) 54:3682-9. doi:10.1002/art.22164.
13. Nakashima R, Mimori T. Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. Int J Clin Rheumtol (2010) 5:523-36. doi:10.2217/ijr.10.48.
14. Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasians adult-onset myositis. Ann Rheum Dis (2009) 68:1621-5. doi:10.1136/ard.2008.097162.
15. Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Curr Opin Rheumatol (2012) 24:602-8. doi:10.1097/BOR.0b013e328358bd85.
16. Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev (2014) 13:883-91. doi:10.1016/j.autrev.2014.03.004.